Infertility

The company generates three-quarters of its sales from the multiple-sclerosis medicine Rebif, which was first sold in 1998, and fertility drug Gonal-f, the first biological copy of a follicle-stimulating hormone, that was approved for sale in 1995.

Rebif faces competition from new oral treatments as well as Elan Corp.'s Tysabri, which may return to the market in coming months.

The drugmaker has been buying products to revive growth and move into new disease areas such as oncology and dermatology.

It acquired rights to Genentech Inc.

and Xoma Ltd.'s psoriasis therapy Raptiva outside the U.S.

and Asia and experimental cancer drugs from companies including Genmab A/S and Rigel Pharmaceuticals Inc.

Drug Disappointments Some of the drugs the company bought as well as those it developed weren't successful.

Serono dropped the development of psoriasis treatment onercept and melanoma drug Canvaxin in April 2005 and The company also had to pay $725 million last year to settle a U.S.

government probe.

It pleaded guilty to conspiracy charges for the promotion of AIDS drug Serostim.

The company paid physicians to get them to prescribe the medicine, which fights physical wasting caused by AIDS, the plaintiffs said.

The board may increase the company's author...

The event includes activities May 26 and 27 at Norfork Inn and May 28 at Bull Shoals State Park Pavilion.

The cost is $15 per person and RSVPs are requested.

For information, call Michelle at 425-4559, Rob at 425-5175, Jill at 492-6857, Phillip at 425-2399 or Joel at 425-4067 or e-mail mhhs1981@hotmail.com.Hill Country Art Gallery sets art challenge ADVERTISEMENT Area artists may enter the Hill Country Art Gallery second Community Art Challenge Saturday through Aug.

12.

Area residents who are high school age or older are welcome to submit original artwork on an official 6-by-6-inch canvas.

Applications and official canvases are available at Hill Country Art Gallery, 3670 Hwy.

62 E.

There is $5 entry fee per submission.

A panel of area artists will judge entries for creativity and technique.

Prizes will be awarded at 6 p.m.

Aug.

18 at the gallery.

Winners need not be present.

Submissions will remain on display through Sept.

18 for public viewing.

For rules and information, call Hill Country Art Gallery at 492-4000.

From submitted reports Originally published March 31, 2006 Print this article Email this to a friend Subscribe Now Contact Us Place an ad Copyright ©2006 The Baxter Bulletin.

All rights reserved.

Users of this site agree to th...

Serono generates three-quarters of its sales from the multiple-sclerosis medicine Rebif, which was first sold in 1998, and fertility drug Gonal-f, the first biological copy of a follicle-stimulating hormone, that was approved for sale in 1995.

The company has been buying products to revive growth and move into new disease areas such as oncology and dermatology.

It acquired rights to Genentech Inc.

and Xoma Ltd.'s psoriasis therapy Raptiva outside the U.S.

and Asia and experimental cancer drugs from companies including Genmab A/S and Rigel Pharmaceuticals Inc.

Some of the drugs the company bought as well as those it developed weren't successful.

It dropped the development of psoriasis treatment onercept and melanoma drug Canvaxin in April 2005 and The board may increase the company's authorized capital at once or in installments, Serono said.

The board will be in a position to determine the opportune timing and the optimal conditions for a share issue, the company said in its invitation to shareholders.

To contact the reporter on this story: Chantal Britt in Zurich at cbritt@bloomberg.net.

Last Updated: March 31, 2006 03:07 EST ©2006 Bloomberg L.P.

All rights reserved.

Terms of Service Privacy Policy Trademarks Site Map Help Feedback Abou...